Dengue Vaccine Development and Deployment into Routine Immunization

Dengue has emerged as a significant global health threat. Despite decades of research, only two dengue vaccines—CYD-TDV (Dengvaxia) and TAK-003 (Qdenga)—have been licensed to date, with limited implementation. This paper explores and outlines strategies for integrating dengue vaccines into routine i...

Full description

Bibliographic Details
Published in:Vaccines
Main Authors: Annelies Wilder-Smith, Thomas Cherian, Joachim Hombach
Format: Article
Language:English
Published: MDPI AG 2025-04-01
Subjects:
Online Access:https://www.mdpi.com/2076-393X/13/5/483